Cargando…
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
Autores principales: | Hong, Kyung Soo, Ahn, June Hong, Jang, Jong Geol, Lee, Jong Ho, Kim, Hong Nam, Kim, Dongha, Lee, Wonhwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670835/ https://www.ncbi.nlm.nih.gov/pubmed/33203839 http://dx.doi.org/10.1038/s41392-020-00391-5 |
Ejemplares similares
-
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
por: Kim, Dongha, et al.
Publicado: (2021) -
The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update
por: Malagraba, Gianluca, et al.
Publicado: (2022) -
PKCα-mediated phosphorylation of LSD1 is required for presynaptic plasticity and hippocampal learning and memory
por: Lim, Chae-Seok, et al.
Publicado: (2017) -
Lsd1 Ablation Triggers Metabolic Reprogramming of Brown Adipose Tissue
por: Duteil, Delphine, et al.
Publicado: (2016) -
The lasting influence of LSD1 in the blood
por: Dent, Sharon YR, et al.
Publicado: (2013)